Bank Of America Corp Exelixis, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Exelixis, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,909,710 shares of EXEL stock, worth $85.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,909,710

Previous 1,214,689 57.22%

Holding current value

$85.3 Million

Previous $40.4 Million 74.31%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$32.38 - $39.16 $22.5 Million - $27.2 Million	695,021 Added 57.22%	1,909,710 $70.5 Million
Q4 2024 Feb 14, 2025	BUY	$25.39 - $36.46 $1.41 Million - $2.02 Million	55,507 Added 4.79%	1,214,689 $40.4 Million
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $109,712 - $137,889	-4,996 Reduced 0.43%	1,159,182 $30.1 Million
Q2 2024 Aug 14, 2024	BUY	$20.34 - $23.73 $2.77 Million - $3.24 Million	136,380 Added 13.27%	1,164,178 $26.2 Million
Q1 2024 May 15, 2024	SELL	$20.17 - $23.93 $11.4 Million - $13.5 Million	-563,634 Reduced 35.42%	1,027,798 $24.4 Million
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $7 Million - $8.78 Million	363,873 Added 29.64%	1,591,432 $38.2 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $3.36 Million - $3.79 Million	-185,132 Reduced 13.1%	1,227,559 $23.5 Million
Q1 2023 May 12, 2023	BUY	$16.3 - $19.41 $5.19 Million - $6.19 Million	318,685 Added 29.13%	1,412,691 $27.4 Million
Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $5.35 Million - $6.22 Million	-357,741 Reduced 24.64%	1,094,006 $17.5 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $1.19 Million - $1.7 Million	-76,198 Reduced 4.99%	1,451,747 $22.8 Million
Q2 2022 Aug 12, 2022	BUY	$17.44 - $23.16 $5.49 Million - $7.29 Million	314,735 Added 25.94%	1,527,945 $31.8 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $5.47 Million - $7.29 Million	321,466 Added 36.05%	1,213,210 $27.5 Million
Q4 2021 Feb 08, 2022	BUY	$15.84 - $21.88 $2.39 Million - $3.31 Million	151,112 Added 20.4%	891,744 $16.3 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $2.25 Million - $2.92 Million	138,004 Added 22.9%	740,632 $15.7 Million
Q2 2021 Sep 13, 2021	BUY	$17.95 - $25.56 $10.8 Million - $15.4 Million	602,628 New	602,628 $11 Million

Others Institutions Holding EXEL

# of Institutions

607

Shares Held

256M

Call Options Held

1.57M

Put Options Held

730K

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $14.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Exelixis, Inc. Transaction History